Abstract
Multiple endocrine neoplasia type 2 is an autosomal-dominant hereditary cancer syndrome caused by missense gain-of-function mutations of the rearranged during transfection proto-oncogene, which encodes the receptor tyrosine kinase, on chromosome 10. It has a strong penetrance of medullary thyroid carcinomas and can be associated with bilateral pheochromocytoma and primary hyperparathyroidism. Multiple endocrine neoplasia type 2 is divided into three varieties depending on its clinical features: multiple endocrine neoplasia type 2A, multiple endocrine neoplasia type 2B, and familial medullary thyroid carcinoma. The specific rearranged during transfection mutation may suggest a predilection toward a particular phenotype and clinical course of medullary thyroid carcinoma, with strong genotype-phenotype correlations. Offering rearranged during transfection testing is the best practice for the clinical management of patients at risk of developing multiple endocrine neoplasia type 2, and multiple endocrine neoplasia type 2 has become a classic model for the integration of molecular medicine into patient care. Recommendations on the timing of prophylactic thyroidectomy and extent of surgery are based on the classification of rearrange...Continue Reading
Citations
Jun 1, 2018·Case Reports in Endocrinology·Jin Wook YiSung Sup Park
Aug 22, 2015·International Journal of Endocrinology·T C SchneiderE Kapiteijn
Oct 7, 2015·World Journal of Surgery·Sendhil RajanEesh Bhatia
Aug 1, 2019·Cancers·Karen KoopmanRonald R de Krijger
Dec 4, 2013·Langenbeck's Archives of Surgery·Bruno NiederleMichael Brauckhoff
Jun 4, 2014·Clinical Endocrinology·David TaïebKarel Pacak
Oct 27, 2015·Endocrine Journal·Claudia ScolloGabriella Pellegriti
Aug 8, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Antonella VerrientiRocco Bruno
Sep 8, 2017·Human Mutation·Luís CardosoRajesh V Thakker
Mar 20, 2014·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Y Martinez-CriadoI Fernandez-Pineda
Jun 7, 2014·International Journal of Surgical Pathology·Pedro SantosAntonio Taveira-Gomes
Mar 27, 2015·Thyroid : Official Journal of the American Thyroid Association·Samuel A WellsUNKNOWN American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma
Dec 19, 2015·Critical Reviews in Clinical Laboratory Sciences·Mehdi HedayatiFarinaz Afsari
Jul 26, 2019·Journal of Pediatric Endocrinology & Metabolism : JPEM·Cristina Garcés VisierJose Lorenzo Alonso Calderón
Jan 18, 2018·The British Journal of Surgery·H M RossittiO Gimm
Sep 13, 2019·Genes·Rossella EliseiCristina Romei
Oct 20, 2020·Frontiers in Endocrinology·Shu-Yuan LiXiao-Ping Qi
Jul 5, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jonathan D WassermanJoshua D Schiffman
Feb 8, 2021·Mayo Clinic Proceedings·Lori A Erickson
Apr 5, 2021·Seminars in Cancer Biology·Jes Sloth MathiesenUlla Feldt-Rasmussen